[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2010/64722,2010,A1Locationinpatent:Page/Pagecolumn192
[1]Okaniwa,Masanori;Hirose,Masaaki;Arita,Takeo;Yabuki,Masato;Nakamura,Akito;Takagi,Terufumi;Kawamoto,Tomohiro;Uchiyama,Noriko;Sumita,Akihiko;Tsutsumi,Shunichirou;Tottori,Tsuneaki;Inui,Yoshitaka;Sang,Bi-Ching;Yano,Jason;Aertgeerts,Kathleen;Yoshida,Sei;Ishikawa,Tomoyasu[JournalofMedicinalChemistry,2013,vol.56,#16,p.6478-6494]
[1]Okaniwa,Masanori;Hirose,Masaaki;Arita,Takeo;Yabuki,Masato;Nakamura,Akito;Takagi,Terufumi;Kawamoto,Tomohiro;Uchiyama,Noriko;Sumita,Akihiko;Tsutsumi,Shunichirou;Tottori,Tsuneaki;Inui,Yoshitaka;Sang,Bi-Ching;Yano,Jason;Aertgeerts,Kathleen;Yoshida,Sei;Ishikawa,Tomoyasu[JournalofMedicinalChemistry,2013,vol.56,#16,p.6478-6494]
[1]Okaniwa,Masanori;Hirose,Masaaki;Arita,Takeo;Yabuki,Masato;Nakamura,Akito;Takagi,Terufumi;Kawamoto,Tomohiro;Uchiyama,Noriko;Sumita,Akihiko;Tsutsumi,Shunichirou;Tottori,Tsuneaki;Inui,Yoshitaka;Sang,Bi-Ching;Yano,Jason;Aertgeerts,Kathleen;Yoshida,Sei;Ishikawa,Tomoyasu[JournalofMedicinalChemistry,2013,vol.56,#16,p.6478-6494]
[1]Okaniwa,Masanori;Hirose,Masaaki;Arita,Takeo;Yabuki,Masato;Nakamura,Akito;Takagi,Terufumi;Kawamoto,Tomohiro;Uchiyama,Noriko;Sumita,Akihiko;Tsutsumi,Shunichirou;Tottori,Tsuneaki;Inui,Yoshitaka;Sang,Bi-Ching;Yano,Jason;Aertgeerts,Kathleen;Yoshida,Sei;Ishikawa,Tomoyasu[JournalofMedicinalChemistry,2013,vol.56,#16,p.6478-6494]
Title: Okaniwa M, et al. Discovery of a selective kinase inhibitor (TAK-632) targeting pan-RAF inhibition: design, synthesis, and biological evaluation of C-7-substituted 1,3-benzothiazole derivatives. J Med Chem. 2013 Aug 22;56(16):6478-94.
Title: Nakamura A, et al. Antitumor activity of the selective pan-RAF inhibitor TAK-632 in BRAF inhibitor-resistant melanoma. Cancer Res. 2013 Oct 11.
